Medical Oncology

Doç. Dr. Ozan Balakan

Doctor and researcher Liv Hospital Bahçeşehir İstanbul
Breast NeoplasmsAdenocarcinomaPancreatic NeoplasmsColorectal NeoplasmsBreast Neoplasms, MaleMelanomaLiver NeoplasmsLung Neoplasms

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Breast Neoplasms 9 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Adenocarcinoma 4 publications
  • Pancreatic Neoplasms 3 publications
  • Colorectal Neoplasms 2 publications
  • Breast Neoplasms, Male 2 publications
  • Melanoma 2 publications
  • Liver Neoplasms 2 publications
  • Lung Neoplasms 2 publications

Person ↔ Disease

Which topics does this doctor work on?

From source

Medical areas of interest stated by the doctor on the institution profile. Source: livhospital.com.

  • Meme kanseri
  • Gastrointestinal sistem kanserleri
  • Akciğer kanseri
  • Nöroendokrin tümörler
  • Santral sinir sistemi kanserleri

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyMedical Oncologylivhospital.comFrom source
  • InstitutionLiv Hospital Bahçeşehirlivhospital.comFrom source
  • Area of workBreast NeoplasmsExtracted from 9 publications · Model version —From source
  • Publications117 publicationsOpenAlexFrom source
  • Last synchronised4 November 2026 21:01https://www.livhospital.com/doc-dr-ozan-balakanlivhospital.com

Scientific work

Publications on Breast Neoplasms

117 publications
  1. Awareness of cancer diagnosis in Turkish patients can increase anxiety and depression: is it true?

    Annals of Oncology, 2016

    DOI 10.1093/annonc/mdw390.72 Source: OpenAlex

  2. Correlation of educational status and clinicopathological characteristics of breast cancer: a single center experience.

    PubMed, 2016

    PMID 27685902 1 citation (Europe PMC) Source: OpenAlex

  3. TRP GENES FAMILY EXPRESSION IN COLORECTAL CANCER

    Experimental Oncology, 2015

    DOI 10.31768/2312-8852.2015.37(3):208-212 PMID 26422106 36 citations (Europe PMC) Open-access full textSource: OpenAlex

  4. Clinical Significance of HER2 Overexpression in Gastric and Gastroesophageal Junction Cancers

    Journal of Gastrointestinal Surgery, 2015

    DOI 10.1007/s11605-015-2888-y PMID 26179664 19 citations (Europe PMC) Source: OpenAlex

  5. Efficacy of capecitabine monotherapy as the first-line treatment of metastatic HER-2 negative breast cancer.

    Journal of Clinical Oncology, 2015

    DOI 10.1200/jco.2015.33.15_suppl.e12035 Source: OpenAlex

  6. Micronucleus Score in the Buccal Mucosa of Women with Breast Cancer and the Relationship to Chemotherapy

    Asian Journal of Pharmacy Nursing and Medical Sciences, 2015

    DOI 10.24203/ajpnms.v3i4.3164.g1632 Source: OpenAlex

  7. Correlation of educational status and clinicopathological characteristics of breast cancer: A single center experience.

    Journal of Clinical Oncology, 2015

    DOI 10.1200/jco.2015.33.15_suppl.e11549 Source: OpenAlex

  8. Efficacy of Capecitabine Monotherapy as the First-line Treatment of Metastatic HER2-negative Breast Cancer

    Tumori Journal, 2015

    DOI 10.5301/tj.5000332 PMID 25953439 6 citations (Europe PMC) Source: OpenAlex

  9. The effect of renin-angiotensin-system inhibition on survival and recurrence of N3+ breast cancer patients.

    PubMed, 2015

    PMID 25778296 12 citations (Europe PMC) Source: OpenAlex

  10. A retrospective analysis of adjuvant CAF, AC-T and TAC regimens in triple negative early stage breast cancer.

    PubMed, 2015

    PMID 25778291 4 citations (Europe PMC) Source: OpenAlex

View all 117 publications